Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Handbook of Experimental Pharmacology|March 10, 2017
Mechanisms of Drug Resistance in MelanomaMatthew Winder, Amaya Virós
The Journal of Investigative Dermatology|October 20, 2021
Positive Attributes of Anti-TERT CD4 T-Helper Type 1 Immune Responses in MelanomaEduardo Nagore, Amaya Virós, Rajiv Kumar
Cancer Discovery|June 5, 2016
So You Can Teach Old Fibroblasts New TricksAmaya Virós, Maria Romina Girotti, Richard Marais
The Journal of Pathology|January 31, 2018
Ultraviolet light and melanomaSarah Craig, Charles H Earnshaw, Amaya Virós
Cancers|July 27, 2022
3D Bioprinting: An Enabling Technology to Understand MelanomaSamantha Fernandes, Cian Vyas, Peggy Lim, et al.
JAMA Dermatology|May 9, 2019
Histologic Features Associated With an Invasive Component in Lentigo Maligna LesionsAngela Moreno, Esperanza Manrique-Silva, Amaya Virós, et al.
Pediatric Dermatology|September 16, 2008
Eruptive juvenile xanthogranuloma associated with relapsing acute lymphoblastic leukemiaGloria Aparicio, Jordi Mollet, Ramon Bartralot, et al.
Oncotarget|December 13, 2017
Cutaneous melanoma primary site is linked to nevus densityAlejandro Martin-Gorgojo, Marta Llinares, Amaya Virós, et al.
Oncotarget|January 8, 2019
Correction: Cutaneous melanoma primary site is linked to nevus densityAlejandro Martin-Gorgojo, Marta Llinares, Amaya Virós, et al.
Pigment Cell & Melanoma Research|December 28, 2023
Clinical, histological, and molecular differences in melanoma due to different TERT promoter mutations subtypes. A retrospective cross-sectional study in 684 melanoma patientsEsperanza Manrique-Silva, Millán-Esteban David, Aguerralde-Martin Maider, et al.
Pageof 2